20/20 Biolabs furnishes Sept 2026 investor presentation; no financial detail disclosed

20/20 Biolabs, Inc.

20/20 Biolabs (AIDX) furnished an investor presentation, dated September 2026, for use in a Sept 2, 2026 investor webinar.
Presentation text included in the exhibit contains only a cover slide; no revenue, EPS, pipeline, or guidance figures were provided.
CEO Jonathan Cohen signed the 8-K; no operational or financial updates were disclosed in the filing body or exhibit.
Material news content could not be extracted from the available exhibit text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.